Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 11;8(1):1302652.
doi: 10.1080/20008198.2017.1302652. eCollection 2017.

Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals

Jessie L Frijling  1
Affiliations

Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals

Jessie L Frijling. Eur J Psychotraumatol. .

Abstract

Background: Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder which develops in approximately 10% of trauma-exposed individuals. Currently, there are few early preventive interventions available for PTSD. Intranasal oxytocin administration early posttrauma may prevent PTSD symptom development, as oxytocin administration was previously found to beneficially impact neurobiological (e.g. amygdala reactivity) and socio-emotional PTSD vulnerability factors. Objective: The overall aim of this dissertation was to investigate the potential of intranasal oxytocin administration as early preventive intervention for PTSD. Methods: We performed a functional magnetic resonance imaging (fMRI) study to assess the acute effects of a single administration of oxytocin on the functional fear neurocircuitry - consisting of the amygdala and (pre)frontal brain regions - in recently trauma-exposed emergency department patients (range n = 37-41). In addition, we performed a multicentre randomized double-blind placebo-controlled clinical trial (RCT) to assess the efficacy of repeated intranasal oxytocin administration early after trauma for preventing PTSD symptom development up to six months posttrauma (n = 107). Results: In our fMRI experiments we observed acutely increased amygdala reactivity to fearful faces and attenuated amygdala-ventromedial and ventrolateral prefrontal cortex functional connectivity after a single oxytocin administration in recently trauma-exposed individuals. However, in our RCT we found that repeated intranasal oxytocin administration early posttrauma reduced subsequent PTSD symptom development in recently trauma-exposed emergency department patients with high acute PTSD symptoms. Conclusions: These findings indicate that repeated intranasal oxytocin is a promising early preventive intervention for PTSD for individuals at increased risk for PTSD due to high acute symptom severity. Administration frequency dependent effects of oxytocin or the effects of oxytocin administration on salience processing may serve as explanatory frameworks for the contrasting oxytocin effects on anxiety-related measures in our clinical and neuroimaging studies.

Keywords: PTSD; amygdala; early intervention; fMRI; oxytocin; prevention.

PubMed Disclaimer

References

    1. Acheson D., Feifel D., de Wilde S., Mckinney R., Lohr J., Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology. 2013;229(1):199–13. doi: 10.1007/s00213-013-3130-9. - DOI - PMC - PubMed
    1. Acheson D. T., Feifel D., Kamenski M., Mckinney R., Risbrough V. B. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depression and Anxiety. 2015;32(6):400–407. doi: 10.1002/da.22362. - DOI - PubMed
    1. Admon R., Lubin G., Stern O., Rosenberg K., Sela L., Ben-Ami H., Hendler T. Human vulnerability to stress depends on amygdala’s predisposition and hippocampal plasticity. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(33):14120–14125. doi: 10.1073/pnas.0903183106. - DOI - PMC - PubMed
    1. Admon R., Milad M. R., Hendler T. A causal model of post-traumatic stress disorder: Disentangling predisposed from acquired neural abnormalities. Trends in Cognitive Sciences. 2013;17(7):337–347. doi: 10.1016/j.tics.2013.05.005. - DOI - PubMed
    1. Baldwin D. S., Anderson I. M., Nutt D. J., Allgulander C., Bandelow B., den Boer J. A., Wittchen H.-U. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology (Oxford, England) 2014;28(5):403–439. doi: 10.1177/0269881114525674. - DOI - PubMed

LinkOut - more resources